1995
DOI: 10.1006/mpat.1995.0037
|View full text |Cite
|
Sign up to set email alerts
|

Vaccination of mice with attenuated mutants ofListeria monocytogenes: requirement for induction of macrophage la expression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1997
1997
2010
2010

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Overall, it seems that CtsR and the Clp proteins have a highly fine‐tuned role in virulence and stress response. Further investigation of the role of stress response systems in the virulence of L. monocytogenes may contribute to the rational design of attenuated bacterial vaccines and vaccine delivery systems, in which attenuated bacteria should infect and persist for long enough to provoke protective immunity without causing symptoms of disease (Von Koenig et al ., 1982; Gahan and Collins, 1995; Guzman et al ., 1997).…”
Section: Discussionmentioning
confidence: 99%
“…Overall, it seems that CtsR and the Clp proteins have a highly fine‐tuned role in virulence and stress response. Further investigation of the role of stress response systems in the virulence of L. monocytogenes may contribute to the rational design of attenuated bacterial vaccines and vaccine delivery systems, in which attenuated bacteria should infect and persist for long enough to provoke protective immunity without causing symptoms of disease (Von Koenig et al ., 1982; Gahan and Collins, 1995; Guzman et al ., 1997).…”
Section: Discussionmentioning
confidence: 99%
“…Attenuation through mutation of classical virulence factors would therefore affect the efficacy of our system. It is likely that other approaches, such as the creation of auxotrophic mutants, as described by others, 15,16 will have to be implemented when developing L. monocytogenes bactofection vehicles so as to retain intracellular growth and cell spread but limit virulence for the host. It will be a challenge to select the correct mutant strain to provide an adequate level of vector amplification in vivo whilst maintaining a significant degree of attenuation to ensure safety.…”
Section: The Balance Between Safety and Efficacymentioning
confidence: 99%